Orally active 1-(cyclohexyloxycarbonyloxy)alkyl ester prodrugs of cefotiam.
Authors:
- Tatsuo NishimuraTNTatsuo Nishimura
- Yoshinobu YoshimuraYYYoshinobu Yoshimura
- Akio MiyakeAMAkio Miyake
- Masayoshi YamaokaMYMasayoshi Yamaoka
- Kunio TakanohashiKTKunio Takanohashi
- Naoru HamaguchiNHNaoru Hamaguchi
- Shinichiro HiraiSHShinichiro Hirai
- Takatsuka YashikiTYTakatsuka Yashiki
- Mitsuo NumataMNMitsuo Numata
- 1 January 1987
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 40 (1) , 81-90
Abstract
Orally active 1-(alkyl substituted cyclohexyloxycarbonyloxy)alkyl ester prodrugs (9b.apprx.h) of 7.beta.-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylic acid (cefotiam, CTM) have been studied as well as the thia (9i) and aza (9i) analogs. These represent derivatives of the 1-(cyclohexylacetoxy)ethyl ester (2) of CTM. The syntheses and oral bioavailability (BA) in mice are described. Among them, the 1-(cyclohexyloxycarbonyloxy)butyl ester (9h) gave the highest BA, 93.5%; the esters having a cyclohexyloxy group in the ester moiety gave BAs of more than 75%, although the BA of the 1-(ethoxycarbonyloxy)ethyl ester (9a) was only 23.9%. The thia analog showed a moderate BA, 46%, but the aza analog, 9j, did not show a BA of CTM. These results indicate that the 1-(substituted cyclohexyloxycarbonyloxy)alkyl group was the suitable promoiety to improve the oral BA of CTM. Chiral 1-(alkoxycarbonyloxy)alkyl groups used as the ester moiety, gave an almost 1:1 mixture of diastereoisomeric esters. These were tested as such. However, an experiment in which the separated isomers of the 1-(cyclohexyloxycarbonyloxy)ethyl ester (9d) were administered orally confirmed that both diastereoisomers gave identical BAs.Keywords
This publication has 3 references indexed in Scilit:
- Studles on β-Lactam Antibiotics for Medicinal Purpose. XVIIIYAKUGAKU ZASSHI, 1986
- Preparation of 1-acyloxyethyl esters of 7-(2-(2-aminothiazol-4-yl)acetamido)-3-(((1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl)thio)methyl)ceph-3-em-4-carboxylic acid (cefotiam) and their oral absorption in mice.The Journal of Antibiotics, 1986
- Synthesis and relation between physicochemical properties and oral absorption of 7-O-acylmandelamido-3-methyl-3-cephem-4-carboxylic acids☆International Journal of Pharmaceutics, 1985